1. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Issue 2 (24th August 2005) Authors: Biancone, L; Orlando, A; Kohn, A; Colombo, E; Sostegni, R; Angelucci, E; Rizzello, F; Castiglione, F; Benazzato, L; Papi, C; Meucci, G; Riegler, G; Petruzziello, C; Mocciaro, F; Geremia, A; Calabrese, E; Cottone, M; Pallone, F Journal: Gut Issue: Volume 55:Issue 2(2006) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P119 Surgical recurrence in Crohn's disease patients with severe post-operative endoscopic recurrence: risk difference between purely anastomotic lesions and lesions limited to the neoterminal ileum. (25th January 2019) Authors: Mocciaro, F; Giunta, M; Di Mitri, R; Scimeca, D; Renna, S; Conte, E; Bonaccorso, A; Cappello, M; Scrivo, B; Casà, A; Malizia, G; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P129 Endoscopy and inflammatory bowel disease: data from a pilot experience to investigate the gap between the current guidelines and the real clinical practice. (25th January 2019) Authors: Mocciaro, F; Magro, B; Conte, E; Bonaccorso, A; Scimeca, D; Di Mitri, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P215 Blood-based prognostic biomarkers in Crohn's patients treated with biologics: a new promising tool to predict endoscopic outcomes. (27th May 2021) Authors: Grova, M; Crispino, F; Maida, M; Renna, S; Mocciaro, F; Casà, A; Rizzuto, G; Scimeca, D; Di Mitri, R; Macaluso, F S; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P288 Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn's Disease. (27th May 2021) Authors: Macaluso, F S; Cappello, M; Crispino, F; Grova, M; Privitera, A C; Piccillo, G; Magnano, A; Ferracane, C; Belluardo, N; Giangreco, E; Fries, W; Viola, A; Di Mitri, R; Mocciaro, F; Camilleri, S; Garufi, S; Renna, S; Casà, A; Maida, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P325 A propensity score-weighted comparison of vedolizumab and adalimumab in Crohn's disease: Real-life data from the Sicilian Network for inflammatory bowel disease (SN-IBD). (15th January 2020) Authors: Macaluso, F S; Ventimiglia, M; Fries, W; Viola, A; Sitibondo, A; Cappello, M; Scrivo, B; Busacca, A; Privitera, A C; Camilleri, S; Garufi, S; Di Mitri, R; Mocciaro, F; Belluardo, N; Giangreco, E; Bertolami, C; Renna, S; Orlando, R; Rizzuto, G; Cottone, M Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P396 Ustekinumab Is A Promising Option For The Treatment Of Postoperative Recurrence Of Crohn's Disease. (30th January 2023) Authors: Macaluso, F S; Grova, M; Mocciaro, F; Di Mitri, R; Privitera, A C; Distefano, M E; Vitello, A; Camilleri, S; Ferracane, C; Pluchino, D; Belluardo, N; Giangreco, E; Fries, W; Viola, A; Cappello, M; Amato, L; Bertolami, C; Ventimiglia, M; Renna, S; Casà, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P439 Effectiveness of Ustekinumab on Crohn's disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD). (27th May 2021) Authors: Macaluso, F; Fries, W; Viola, A; Costantino, G; Muscianisi, M; Cappello, M; Guida, L; Giuffrida, E; Magnano, A; Pluchino, D; Ferracane, C; Magrì, G; Di Mitri, R; Mocciaro, F; Privitera, A C; Camilleri, S; Garufi, S; Renna, S; Casà, A; Scrivo, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P545 Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD). (25th January 2019) Authors: Porcari, S; Fidanza, O; Alibrandi, A; Renna, S; Cappello, M; Siringo, S; Privitera, A; Inserra, G; Mocciaro, F; Magri, G; Carroccio, A; Belluardo, N; Bertolami, C; Garufi, S; Ventimiglia, M; Macaluso, F; Viola, A; Cottone, M; Orlando, A; Fries, W Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P570 Safety and Effectiveness of Tofacitinib in Ulcerative Colitis: Real-world Data from TOFA-UC, a SN-IBD Study. (30th January 2023) Authors: Macaluso, F S; D'Antonio, E; Fries, W; Viola, A; Ksissa, O; Cappello, M; Muscarella, S; Belluardo, N; Giangreco, E; Mocciaro, F; Di Mitri, R; Ferracane, C; Vitello, A; Grova, M; Renna, S; Casà, A; Ventimiglia, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗